-
1
-
-
84897407751
-
The clinical management of chronic myelomonocytic leukemia
-
Padron E, Komrokji R, List AF. The clinical management of chronic myelomonocytic leukemia. Clin Adv Hematol Oncol 2014; 12: 172-178.
-
(2014)
Clin Adv Hematol Oncol
, vol.12
, pp. 172-178
-
-
Padron, E.1
Komrokji, R.2
List, A.F.3
-
2
-
-
84883619210
-
Management recommendations for chronic myelomonocytic leukemia: Consensus statements from the SIE, SIES, GITMO groups
-
Onida F, Barosi G, Leone G, Malcovati L, Morra E, Santini V et al. Management recommendations for chronic myelomonocytic leukemia: Consensus statements from the SIE, SIES, GITMO groups. Haematologica 2013; 98: 1344-1352.
-
(2013)
Haematologica
, vol.98
, pp. 1344-1352
-
-
Onida, F.1
Barosi, G.2
Leone, G.3
Malcovati, L.4
Morra, E.5
Santini, V.6
-
3
-
-
0017162163
-
Proposals for the classification of the acute leukaemias French-American-British (FAB) Co-operative Group
-
Bennett JM, Catovsky D, Daniel M-T, Flandrin G, Galton DAG, Gralnick HR et al. Proposals for the classification of the acute leukaemias French-American-British (FAB) Co-operative Group. Br J Haematol 1976; 33: 451-458.
-
(1976)
Br J Haematol
, vol.33
, pp. 451-458
-
-
Bennett, J.M.1
Catovsky, D.2
Daniel, M.-T.3
Flandrin, G.4
Galton, D.A.G.5
Gralnick, H.R.6
-
4
-
-
70349256226
-
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: Rationale and important changes
-
Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: Rationale and important changes. Blood 2009; 114: 937-951.
-
(2009)
Blood
, vol.114
, pp. 937-951
-
-
Vardiman, J.W.1
Thiele, J.2
Arber, D.A.3
Brunning, R.D.4
Borowitz, M.J.5
Porwit, A.6
-
5
-
-
84888219405
-
Clinical and biological implications of driver mutations in myelodysplastic syndromes
-
Papaemmanuil E, Gerstung M, Malcovati L, Tauro S, Gundem G, Van Loo P et al. Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood 2013; 122: 3616-3627.
-
(2013)
Blood
, vol.122
, pp. 3616-3627
-
-
Papaemmanuil, E.1
Gerstung, M.2
Malcovati, L.3
Tauro, S.4
Gundem, G.5
Van Loo, P.6
-
6
-
-
84877928684
-
Clonal architecture of chronic myelomonocytic leukemias
-
Itzykson R, Kosmider O, Renneville A, Morabito M, Preudhomme C, Berthon C et al. Clonal architecture of chronic myelomonocytic leukemias. Blood 2013; 121: 2186-2198.
-
(2013)
Blood
, vol.121
, pp. 2186-2198
-
-
Itzykson, R.1
Kosmider, O.2
Renneville, A.3
Morabito, M.4
Preudhomme, C.5
Berthon, C.6
-
7
-
-
84905907421
-
ETV6 and signaling gene mutations are associated with secondary transformation of myelodysplastic syndromes to chronic myelomonocytic leukemia
-
Padron E, Yoder S, Kunigal S, Mesa T, Teer JK, Al Ali N et al. ETV6 and signaling gene mutations are associated with secondary transformation of myelodysplastic syndromes to chronic myelomonocytic leukemia. Blood 2014; 123: 3675-3677.
-
(2014)
Blood
, vol.123
, pp. 3675-3677
-
-
Padron, E.1
Yoder, S.2
Kunigal, S.3
Mesa, T.4
Teer, J.K.5
Al Ali, N.6
-
8
-
-
84882396666
-
GM-CSF-dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemia
-
Padron E, Painter JS, Kunigal S, Mailloux AW, McGraw K, McDaniel JM et al. GM-CSF-dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemia. Blood 2013; 121: 5068-5077.
-
(2013)
Blood
, vol.121
, pp. 5068-5077
-
-
Padron, E.1
Painter, J.S.2
Kunigal, S.3
Mailloux, A.W.4
McGraw, K.5
McDaniel, J.M.6
-
9
-
-
84880263477
-
Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes
-
Patnaik MM, Padron E, Laborde RR, Lasho TL, Finke CM, Hanson CA et al. Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes. Leukemia 2013; 27: 1504-1510.
-
(2013)
Leukemia
, vol.27
, pp. 1504-1510
-
-
Patnaik, M.M.1
Padron, E.2
Laborde, R.R.3
Lasho, T.L.4
Finke, C.M.5
Hanson, C.A.6
-
10
-
-
84866621729
-
Revised International Prognostic Scoring System (IPSS-R) for myelodysplastic syndromes
-
Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Sole F et al. Revised International Prognostic Scoring System (IPSS-R) for myelodysplastic syndromes. Blood 2012; 120: 2454-2465.
-
(2012)
Blood
, vol.120
, pp. 2454-2465
-
-
Greenberg, P.L.1
Tuechler, H.2
Schanz, J.3
Sanz, G.4
Garcia-Manero, G.5
Sole, F.6
-
11
-
-
0030897009
-
International scoring system for evaluating prognosis in myelodysplastic syndromes
-
Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997; 89: 2079-2088.
-
(1997)
Blood
, vol.89
, pp. 2079-2088
-
-
Greenberg, P.1
Cox, C.2
LeBeau, M.M.3
Fenaux, P.4
Morel, P.5
Sanz, G.6
-
12
-
-
84877069358
-
Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia
-
Such E, Germing U, Malcovati L, Cervera J, Kuendgen A, Della Porta MG et al. Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia. Blood 2013; 121: 3005-3015.
-
(2013)
Blood
, vol.121
, pp. 3005-3015
-
-
Such, E.1
Germing, U.2
Malcovati, L.3
Cervera, J.4
Kuendgen, A.5
Della Porta, M.G.6
-
13
-
-
0026504855
-
Primary myelodysplastic syndromes: Analysis of prognostic factors in 235 patients and proposals for an improved scoring system
-
Aul C, Gattermann N, Heyll A, Germing U, Derigs G, Schneider W. Primary myelodysplastic syndromes: Analysis of prognostic factors in 235 patients and proposals for an improved scoring system. Leukemia 1992; 6: 52-59.
-
(1992)
Leukemia
, vol.6
, pp. 52-59
-
-
Aul, C.1
Gattermann, N.2
Heyll, A.3
Germing, U.4
Derigs, G.5
Schneider, W.6
-
14
-
-
84922336738
-
Prognostic score including gene mutations in chronic myelomonocytic leukemia
-
Itzykson R, Kosmider O, Renneville A, Gelsi-Boyer V, Meggendorfer M, Morabito M et al. Prognostic score including gene mutations in chronic myelomonocytic leukemia. Journal of clinical oncology: Official journal of the American Society of Clinical Oncology 2013; 31: 2428-2436.
-
(2013)
Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
, vol.31
, pp. 2428-2436
-
-
Itzykson, R.1
Kosmider, O.2
Renneville, A.3
Gelsi-Boyer, V.4
Meggendorfer, M.5
Morabito, M.6
-
15
-
-
84922332658
-
ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: A two-center study of 466 patients
-
Patnaik MM, Itzykson R, Lasho TL, Kosmider O, Finke CM, Hanson CA et al. ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: A two-center study of 466 patients. Leukemia 2014; 28: 2206-2212.
-
(2014)
Leukemia
, vol.28
, pp. 2206-2212
-
-
Patnaik, M.M.1
Itzykson, R.2
Lasho, T.L.3
Kosmider, O.4
Finke, C.M.5
Hanson, C.A.6
-
16
-
-
84922393115
-
Molecular and prognostic correlates of cytogenetic abnormalities in chronic myelomonocytic leukemia: A Mayo Clinic-French Consortium Study
-
Wassie EA, Itzykson R, Lasho TL, Kosmider O, Finke CM, Hanson CA et al. Molecular and prognostic correlates of cytogenetic abnormalities in chronic myelomonocytic leukemia: A Mayo Clinic-French Consortium Study. Am J Hematol 2014; 89: 1111-1115.
-
(2014)
Am J Hematol
, vol.89
, pp. 1111-1115
-
-
Wassie, E.A.1
Itzykson, R.2
Lasho, T.L.3
Kosmider, O.4
Finke, C.M.5
Hanson, C.A.6
-
17
-
-
0036464647
-
Prognostic factors and scoring systems in chronic myelomonocytic leukemia: A retrospective analysis of 213 patients
-
Onida F, Kantarjian HM, Smith TL, Ball G, Keating MJ, Estey EH et al. Prognostic factors and scoring systems in chronic myelomonocytic leukemia: A retrospective analysis of 213 patients. Blood 2002; 99: 840-849.
-
(2002)
Blood
, vol.99
, pp. 840-849
-
-
Onida, F.1
Kantarjian, H.M.2
Smith, T.L.3
Ball, G.4
Keating, M.J.5
Estey, E.H.6
-
18
-
-
53149113768
-
Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System
-
Kantarjian H, O'Brien S, Ravandi F, Cortes J, Shan J, Bennett JM et al. Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System. Cancer 2008; 113: 1351-1361.
-
(2008)
Cancer
, vol.113
, pp. 1351-1361
-
-
Kantarjian, H.1
O'Brien, S.2
Ravandi, F.3
Cortes, J.4
Shan, J.5
Bennett, J.M.6
-
19
-
-
47249150213
-
Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs
-
Rollison DE, Howlader N, Smith MT, Strom SS, Merritt WD, Ries LA et al. Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs. Blood 2008; 112: 45-52.
-
(2008)
Blood
, vol.112
, pp. 45-52
-
-
Rollison, D.E.1
Howlader, N.2
Smith, M.T.3
Strom, S.S.4
Merritt, W.D.5
Ries, L.A.6
-
20
-
-
84921433666
-
The use of medical claims to assess incidence, diagnostic procedures and initial treatment of myelodysplastic syndromes and chronic myelomonocytic leukemia in the Netherlands
-
Dinmohamed AG, van Norden Y, Visser O, Posthuma EF, Huijgens PC, Sonneveld P et al. The use of medical claims to assess incidence, diagnostic procedures and initial treatment of myelodysplastic syndromes and chronic myelomonocytic leukemia in the Netherlands. Leukemia research 2014; 39: 177-182.
-
(2014)
Leukemia research
, vol.39
, pp. 177-182
-
-
Dinmohamed, A.G.1
Van Norden, Y.2
Visser, O.3
Posthuma, E.F.4
Huijgens, P.C.5
Sonneveld, P.6
-
21
-
-
84888259429
-
Clinical characteristics and outcomes of therapy-related chronic myelomonocytic leukemia
-
quiz 2920
-
Takahashi K, Pemmaraju N, Strati P, Nogueras-Gonzalez G, Ning J, Bueso-Ramos C et al. Clinical characteristics and outcomes of therapy-related chronic myelomonocytic leukemia. Blood 2013; 122: 2807-2811; quiz 2920.
-
(2013)
Blood
, vol.122
, pp. 2807-2811
-
-
Takahashi, K.1
Pemmaraju, N.2
Strati, P.3
Nogueras-Gonzalez, G.4
Ning, J.5
Bueso-Ramos, C.6
-
22
-
-
85052770793
-
-
CRC Press: New York, NY, USA
-
Breiman L, Friedman J, Stone CJ, Olshen RA. Classification and Regression Trees. CRC Press: New York, NY, USA, 1984.
-
(1984)
Classification and Regression Trees
-
-
Breiman, L.1
Friedman, J.2
Stone, C.J.3
Olshen, R.A.4
-
23
-
-
0026770594
-
Relative risk trees for censored survival data
-
LeBlanc M, Crowley J. Relative risk trees for censored survival data. Biometrics 1992; 48: 411-425.
-
(1992)
Biometrics
, vol.48
, pp. 411-425
-
-
LeBlanc, M.1
Crowley, J.2
-
24
-
-
79952837540
-
Identifying important risk factors for survival in patient with systolic heart failure using random survival forests
-
Hsich E, Gorodeski EZ, Blackstone EH, Ishwaran H, Lauer MS. Identifying important risk factors for survival in patient with systolic heart failure using random survival forests. Circ Cardiovasc Qual Outcomes 2011; 4: 39-45.
-
(2011)
Circ Cardiovasc Qual Outcomes
, vol.4
, pp. 39-45
-
-
Hsich, E.1
Gorodeski, E.Z.2
Blackstone, E.H.3
Ishwaran, H.4
Lauer, M.S.5
-
25
-
-
84867253750
-
SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)
-
Meggendorfer M, Roller A, Haferlach T, Eder C, Dicker F, Grossmann V et al. SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML). Blood 2012; 120: 3080-3088.
-
(2012)
Blood
, vol.120
, pp. 3080-3088
-
-
Meggendorfer, M.1
Roller, A.2
Haferlach, T.3
Eder, C.4
Dicker, F.5
Grossmann, V.6
-
26
-
-
80053900941
-
Frequent pathway mutations of splicing machinery in myelodysplasia
-
Yoshida K, Sanada M, Shiraishi Y, Nowak D, Nagata Y, Yamamoto R et al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 2011; 478: 64-69.
-
(2011)
Nature
, vol.478
, pp. 64-69
-
-
Yoshida, K.1
Sanada, M.2
Shiraishi, Y.3
Nowak, D.4
Nagata, Y.5
Yamamoto, R.6
-
27
-
-
84859597590
-
Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis
-
Makishima H, Visconte V, Sakaguchi H, Jankowska AM, Abu Kar S, Jerez A et al. Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis. Blood 2012; 119: 3203-3210.
-
(2012)
Blood
, vol.119
, pp. 3203-3210
-
-
Makishima, H.1
Visconte, V.2
Sakaguchi, H.3
Jankowska, A.M.4
Abu Kar, S.5
Jerez, A.6
-
28
-
-
77956237515
-
Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1
-
Kohlmann A, Grossmann V, Klein HU, Schindela S, Weiss T, Kazak B et al. Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1. J Clin Oncol 2010; 28: 3858-3865.
-
(2010)
J Clin Oncol
, vol.28
, pp. 3858-3865
-
-
Kohlmann, A.1
Grossmann, V.2
Klein, H.U.3
Schindela, S.4
Weiss, T.5
Kazak, B.6
-
29
-
-
84915750567
-
Refined medullary blast and white blood cell count based classification of chronic myelomonocytic leukemias
-
Schuler E, Schroeder M, Neukirchen J, Strupp C, Xicoy B, Kundgen A et al. Refined medullary blast and white blood cell count based classification of chronic myelomonocytic leukemias. Leuk Res 2014; 38: 1413-1419.
-
(2014)
Leuk Res
, vol.38
, pp. 1413-1419
-
-
Schuler, E.1
Schroeder, M.2
Neukirchen, J.3
Strupp, C.4
Xicoy, B.5
Kundgen, A.6
-
30
-
-
84863393263
-
Prognostic relevance of integrated genetic profiling in acute myeloid leukemia
-
Patel JP, Gonen M, Figueroa ME, Fernandez H, Sun Z, Racevskis J et al. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N Engl J Med 2012; 366: 1079-1089.
-
(2012)
N Engl J Med
, vol.366
, pp. 1079-1089
-
-
Patel, J.P.1
Gonen, M.2
Figueroa, M.E.3
Fernandez, H.4
Sun, Z.5
Racevskis, J.6
-
31
-
-
84904042955
-
CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: Clinical, cytogenetic and molecular comparisons
-
Tefferi A, Lasho TL, Finke CM, Knudson RA, Ketterling R, Hanson CH et al. CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: Clinical, cytogenetic and molecular comparisons. Leukemia 2014; 28: 1472-1477.
-
(2014)
Leukemia
, vol.28
, pp. 1472-1477
-
-
Tefferi, A.1
Lasho, T.L.2
Finke, C.M.3
Knudson, R.A.4
Ketterling, R.5
Hanson, C.H.6
-
32
-
-
84924566077
-
Expression and prognostic impact of lncRNAs in acute myeloid leukemia
-
Garzon R, Volinia S, Papaioannou D, Nicolet D, Kohlschmidt J, Yan PS et al. Expression and prognostic impact of lncRNAs in acute myeloid leukemia. Proc Natl Acad Sci USA 2014; 111: 18679-18684.
-
(2014)
Proc Natl Acad Sci USA
, vol.111
, pp. 18679-18684
-
-
Garzon, R.1
Volinia, S.2
Papaioannou, D.3
Nicolet, D.4
Kohlschmidt, J.5
Yan, P.S.6
|